Literature DB >> 19629645

A theoretical analysis of secondary structural characteristics of anticancer peptides.

Sarah R Dennison1, Frederick Harris, Tailap Bhatt, Jaipaul Singh, David A Phoenix.   

Abstract

Here, cluster analysis showed that a database of 158 anticancer peptides formed 21 clusters based on net positive charge, hydrophobicity and amphiphilicity. In general, these clusters showed similar median toxicities (P = 0.176) against eukaryotic cell lines and no single combination of these properties was found optimal for efficacy. The database contained 14 peptides, which showed selectivity for tumour cell lines only (ACP(CT)), 123 peptides with general toxicity to eukaryotic cells (ACP(GT)) and 21 inactive peptides (ACP(I)). Hydrophobic arc size analysis showed that there was no significant difference across the datasets although peptides with wide hydrophobic arcs (>270 degrees) appeared to be associated with decreased toxicity. Extended hydrophobic moment plot analysis predicted that over 50% of ACP(CT) and ACP(GT) peptides would be surface active, which led to the suggestion that amphiphilicity is a key driver of the membrane interactions for these peptides but probably plays a role in their efficacy rather than their selectivity. This analysis also predicted that only 14% of ACP(CT) peptides compared to 45% of ACP(GT) peptides were candidates for tilted peptide formation, which led to the suggestion that the absence of this structure may support cancer cell selectivity. However, these analyses predicted that ACP(I) peptides, which possess no anticancer activity, would also form surface active and tilted alpha-helices, clearly showing that other factors are involved in determining the efficacy and selectivity of ACPs.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19629645     DOI: 10.1007/s11010-009-0213-3

Source DB:  PubMed          Journal:  Mol Cell Biochem        ISSN: 0300-8177            Impact factor:   3.396


  14 in total

1.  Use of hydrophobic moment plot methodology to aid the identification of oblique orientated alpha-helices.

Authors:  F Harris; J Wallace; D A Phoenix
Journal:  Mol Membr Biol       Date:  2000 Oct-Dec       Impact factor: 2.857

2.  Are oblique orientated alpha-helices used by antimicrobial peptides for membrane invasion?

Authors:  Sarah R Dennison; Frederick Harris; David A Phoenix
Journal:  Protein Pept Lett       Date:  2005-01       Impact factor: 1.890

Review 3.  Host defense peptides as new weapons in cancer treatment.

Authors:  N Papo; Y Shai
Journal:  Cell Mol Life Sci       Date:  2005-04       Impact factor: 9.261

4.  The interactions of aurein 1.2 with cancer cell membranes.

Authors:  Sarah R Dennison; Frederick Harris; David A Phoenix
Journal:  Biophys Chem       Date:  2006-12-22       Impact factor: 2.352

5.  Design of synthetic antimicrobial peptides based on sequence analogy and amphipathicity.

Authors:  A Tossi; C Tarantino; D Romeo
Journal:  Eur J Biochem       Date:  1997-12-01

6.  Prediction of protein secondary structure at better than 70% accuracy.

Authors:  B Rost; C Sander
Journal:  J Mol Biol       Date:  1993-07-20       Impact factor: 5.469

7.  The helical hydrophobic moment: a measure of the amphiphilicity of a helix.

Authors:  D Eisenberg; R M Weiss; T C Terwilliger
Journal:  Nature       Date:  1982-09-23       Impact factor: 49.962

8.  Interaction of antimicrobial peptides from Australian amphibians with lipid membranes.

Authors:  Isabelle Marcotte; Kate L Wegener; Yuen-Han Lam; Brian C S Chia; Maurits R R de Planque; John H Bowie; Michèle Auger; Frances Separovic
Journal:  Chem Phys Lipids       Date:  2003-01       Impact factor: 3.329

Review 9.  Anticancer alpha-helical peptides and structure/function relationships underpinning their interactions with tumour cell membranes.

Authors:  Sarah R Dennison; Michelle Whittaker; Frederick Harris; David A Phoenix
Journal:  Curr Protein Pept Sci       Date:  2006-12       Impact factor: 3.272

Review 10.  Membrane disrupting lytic peptides for cancer treatments.

Authors:  Carola Leuschner; William Hansel
Journal:  Curr Pharm Des       Date:  2004       Impact factor: 3.116

View more
  9 in total

Review 1.  The dual interaction of antimicrobial peptides on bacteria and cancer cells; mechanism of action and therapeutic strategies of nanostructures.

Authors:  Atefeh Parchebafi; Farzaneh Tamanaee; Hassan Ehteram; Ejaz Ahmad; Hossein Nikzad; Hamed Haddad Kashani
Journal:  Microb Cell Fact       Date:  2022-06-18       Impact factor: 6.352

Review 2.  Membrane-active host defense peptides--challenges and perspectives for the development of novel anticancer drugs.

Authors:  Sabrina Riedl; Dagmar Zweytick; Karl Lohner
Journal:  Chem Phys Lipids       Date:  2011-09-16       Impact factor: 3.329

Review 3.  The Human Cathelicidin Antimicrobial Peptide LL-37 and Mimics are Potential Anticancer Drugs.

Authors:  Kengo Kuroda; Kazuhiko Okumura; Hiroshi Isogai; Emiko Isogai
Journal:  Front Oncol       Date:  2015-06-30       Impact factor: 6.244

Review 4.  Peptides with Dual Antimicrobial and Anticancer Activities.

Authors:  Mário R Felício; Osmar N Silva; Sônia Gonçalves; Nuno C Santos; Octávio L Franco
Journal:  Front Chem       Date:  2017-02-21       Impact factor: 5.221

Review 5.  Anticancer peptide: Physicochemical property, functional aspect and trend in clinical application (Review).

Authors:  Wararat Chiangjong; Somchai Chutipongtanate; Suradej Hongeng
Journal:  Int J Oncol       Date:  2020-07-10       Impact factor: 5.650

Review 6.  Peptides with Dual Antimicrobial-Anticancer Activity: Strategies to Overcome Peptide Limitations and Rational Design of Anticancer Peptides.

Authors:  Yamil Liscano; Jose Oñate-Garzón; Jean Paul Delgado
Journal:  Molecules       Date:  2020-09-16       Impact factor: 4.411

7.  Killing of melanoma cells and their metastases by human lactoferricin derivatives requires interaction with the cancer marker phosphatidylserine.

Authors:  Sabrina Riedl; Beate Rinner; Helmut Schaider; Karl Lohner; Dagmar Zweytick
Journal:  Biometals       Date:  2014-05-18       Impact factor: 2.949

8.  The rational search for selective anticancer derivatives of the peptide Trichogin GA IV: a multi-technique biophysical approach.

Authors:  Annalisa Dalzini; Christian Bergamini; Barbara Biondi; Marta De Zotti; Giacomo Panighel; Romana Fato; Cristina Peggion; Marco Bortolus; Anna Lisa Maniero
Journal:  Sci Rep       Date:  2016-04-04       Impact factor: 4.379

9.  In silico design and optimization of selective membranolytic anticancer peptides.

Authors:  Gisela Gabernet; Damian Gautschi; Alex T Müller; Claudia S Neuhaus; Lucas Armbrecht; Petra S Dittrich; Jan A Hiss; Gisbert Schneider
Journal:  Sci Rep       Date:  2019-08-02       Impact factor: 4.379

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.